Kamal Netralaya Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 29 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.14 Cr
as on 19-12-2024
- Revenue 1.88%
(FY 2020)
- Profit -37.41%
(FY 2020)
- Ebitda -6.26%
(FY 2020)
- Net Worth 51.87%
(FY 2020)
- Total Assets -1.26%
(FY 2020)
About Kamal Netralaya
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.14 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amulya Sahu, Aditya Sahu, Chinmaya Sahu, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110MH1995PTC095165
- Company No.
095165
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kamal Netralaya?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amulya Sahu  | Director | 11-Dec-1995 | Current |
| Chinmaya Sahu | Director | 15-Jan-1999 | Current |
| Aditya Sahu | Director | 13-Nov-2000 | Current |
| Sanjukta Amulya | Director | 11-Dec-1995 | Current |
Financial Performance of Kamal Netralaya.
Kamal Netralaya Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 1.88% increase. The company also saw a substantial fall in profitability, with a 37.41% decrease in profit. The company's net worth Soared by an impressive increase of 51.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kamal Netralaya?
In 2020, Kamal Netralaya had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Indian Syndicate Of Manual Small Incision Cataract SurgeonsActive 14 years 8 months
Amulya Sahu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Operative Bank Ltd Creation Date: 30 Jul 2012 | ₹5.10 M | Satisfied |
The Saraswat Co-Operative Bank Ltd Creation Date: 22 Jun 2012 | ₹2.90 M | Satisfied |
Apna Sahakari Bank Ltd. Creation Date: 11 Aug 2000 | ₹0.50 M | Satisfied |
How Many Employees Work at Kamal Netralaya?
Unlock and access historical data on people associated with Kamal Netralaya, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kamal Netralaya, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamal Netralaya's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
